myTomorrows Expands AI Capabilities to Streamline Patient Recruitment and Communication in Clinical Trials

myTomorrows has announced the expansion of its artificial intelligence (AI) capabilities to enhance support for clinical trial sites globally. The new solution aims to improve workflows at research sites by enabling centralized referral management, providing real-time updates on trials, and facilitating better communication with physicians. These advancements are designed to streamline patient recruitment processes and improve retention rates for clinical research teams worldwide.

The company’s updated platform introduces tools that allow clinical trial sites to manage referrals more efficiently, ensuring that potential participants are matched with appropriate studies in a timely manner. Real-time updates on trial progress will help research teams stay informed and adapt quickly as needed. Additionally, enhanced communication features aim to strengthen collaboration between physicians and research teams, ultimately improving the overall experience for both patients and healthcare providers involved in clinical trials.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: September 18, 2025

Related posts:

Pharmacovigilance Monitors Generic Drug Safety Post-Market to Address Quality Variations from Multiple Manufacturers Venus Remedies Renews GMP Certification in Ukraine for Baddi Facility Producing Antibiotics and Oncology Injectables Guide Highlights Key Criteria for Selecting Vial Filling and Capping Machines in 2025 SUNLIGHT Trial Shows Bevacizumab with Trifluridine/Tipiracil Improves Survival and Quality of Life in Refractory mCRC

Author

Mark Chiang